Surrozen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Surrozen and other ETFs, options, and stocks.About SRZN
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.
CEOCraig C. Parker
CEOCraig C. Parker
Employees41
Employees41
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees41
Employees41
SRZN Key Statistics
Market cap172.25M
Market cap172.25M
Price-Earnings ratio-0.92
Price-Earnings ratio-0.92
Dividend yield—
Dividend yield—
Average volume85.66K
Average volume85.66K
High today$21.40
High today$21.40
Low today$20.00
Low today$20.00
Open price$20.51
Open price$20.51
Volume45.01K
Volume45.01K
52 Week high$24.94
52 Week high$24.94
52 Week low$5.90
52 Week low$5.90
Stock Snapshot
With a market cap of 172.25M, Surrozen(SRZN) trades at $20.00. The stock has a price-to-earnings ratio of -0.92.
During the trading session on 2026-01-17, Surrozen(SRZN) shares reached a daily high of $21.40 and a low of $20.00. At a current price of $20.00, the stock is 0.0% higher than the low and still -6.5% under the high.
Trading volume for Surrozen(SRZN) stock has reached 45.01K, versus its average volume of 85.66K.
The stock's 52-week range extends from a low of $5.90 to a high of $24.94.
The stock's 52-week range extends from a low of $5.90 to a high of $24.94.
People also own
Based on the portfolios of people who own SRZN. This list is generated using Robinhood data, and it’s not a recommendation.